The aim of this study was to determine the frequency of mutation in exon2 (the first translated exon of BRCA2 gene that have not previously been studied in Iran) and exon11 (which comprises over 50% of the gene) of BRCA2 gene in patients with early-onset breast cancer in Iranian Azeri-Turkish women. The gene discussed is BRCA2; the disease is breast carcinoma.